Deutsch
 
Hilfe Datenschutzhinweis Impressum
  DetailsucheBrowse

Datensatz

DATENSATZ AKTIONENEXPORT
Zur Ablage hinzufügen
  Lokale TagsFreigabegeschichteDetailsÜbersicht

Freigegeben
Zeitschriftenartikel

The Biology of CRISPR-Cas: Backward and Forward

MPG-Autoren

Hille,  Frank
Department of Regulation in Infection Biology, Max Planck Institute for Infection Biology, Max Planck Society;

Richter,  Hagen
Department of Regulation in Infection Biology, Max Planck Institute for Infection Biology, Max Planck Society;

Wong,  Shi Pey
Department of Regulation in Infection Biology, Max Planck Institute for Infection Biology, Max Planck Society;

Bratovič,  Majda
Department of Regulation in Infection Biology, Max Planck Institute for Infection Biology, Max Planck Society;

Ressel,  Sarah
Department of Regulation in Infection Biology, Max Planck Institute for Infection Biology, Max Planck Society;

Charpentier,  Emmanuelle
Department of Regulation in Infection Biology, Max Planck Institute for Infection Biology, Max Planck Society;

Externe Ressourcen
Es sind keine externen Ressourcen hinterlegt
Volltexte (beschränkter Zugriff)
Für Ihren IP-Bereich sind aktuell keine Volltexte freigegeben.
Volltexte (frei zugänglich)
Es sind keine frei zugänglichen Volltexte in PuRe verfügbar
Ergänzendes Material (frei zugänglich)
Es sind keine frei zugänglichen Ergänzenden Materialien verfügbar
Zitation

Hille, F., Richter, H., Wong, S. P., Bratovič, M., Ressel, S., & Charpentier, E. (2018). The Biology of CRISPR-Cas: Backward and Forward. Cell, 172(6), 1239-1259. doi:10.1016/j.cell.2017.11.032.


Zitierlink: https://hdl.handle.net/21.11116/0000-0008-7C68-9
Zusammenfassung
In bacteria and archaea, clustered regularly interspaced short palindromic repeats (CRISPR) and CRISPR-associated (Cas) proteins constitute an adaptive immune system against phages and other foreign genetic elements. Here, we review the biology of the diverse CRISPR-Cas systems and the major progress achieved in recent years in understanding the underlying mechanisms of the three stages of CRISPR-Cas immunity: adaptation, crRNA biogenesis, and interference. The ecology and regulation of CRISPR-Cas in the context of phage infection, the roles of these systems beyond immunity, and the open questions that propel the field forward are also discussed.